|
Multiplex Detection of Mutations in Myeloproliferative Disorder and Leukemia Pati
|
1R43CA130501-01
|
$256,027
|
|
YE, FEI
|
AMBION DIAGNOSTICS, INC.
|
|
ApoVax-SVN as a Novel Vaccine for Cancer Immunotherapy
|
1R41CA121665-01A2
|
$328,300
|
|
Shirwan, Haval
|
APOIMMUNE, INC
|
|
Improving the Transfer of ERK siRNA Constructs Using Nanoporous Silica
|
1R41CA126155-01A1
|
$100,000
|
|
Landry, Christopher
|
APOLLO SRI, LLC
|
|
Drug-eluting Tracheobronchial Stents to treat Obstruction caused by Lung Cancer
|
1R43CA119503-01A2
|
$100,000
|
|
SHENOY, NARMADA
|
ARAVASC, INC.
|
|
Effect of VDJ Recombination on Scid B Cell Development
|
3R01CA073857-09S1
|
$1,334
|
|
CHANG, YUNG
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Improved Bladder Cancer Therapy With Recombinant BCG
|
1R43CA130235-01
|
$253,882
|
|
Hone, David
|
BACILLIGEN, INC.
|
|
Food Intake Recording Software System: Version 4
|
1U01CA130762-01
|
$571,282
|
|
Baranowski, Tom
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
$196,947
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Surveillance for Hepatocellular Carcinoma among HCV-infected Veterans
|
1R01CA125487-01A1
|
$291,650
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Molecular Dissection of Tumor Invasion
|
2R01CA087751-06A2
|
$246,598
|
|
GOODE, SCOTT
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
$1,189
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
$2,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
$1,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer
|
3P50CA058183-13S1
|
$153,479
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
$32,031
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of Progression in Oncogene-Incuded Prostate Cancer
|
2R01CA050588-18A2
|
$324,883
|
|
Thompson, Timothy
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Progesterone Receptor Phosphorylation in Target Gene Regulation
|
1F32CA130430-01
|
$46,826
|
|
Ward, Robert
|
BAYLOR COLLEGE OF MEDICINE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-05
|
$98,360
|
$98,360
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Arrayed Microfluidic Device for Reconstituted Tissue Assays
|
9R44CA133909-02
|
$528,122
|
|
HAYES, STEVEN
|
BELLBROOK LABS, LLC
|
|
Training Patients and Partners for HSCT: A Novel Coping Skills Intervention
|
1R03CA130725-01
|
$84,500
|
|
Lawsin, Catalina
|
BERNARD M. BARUCH COLLEGE
|
|
Extracellular Hsp70 and hyperthermia in tumor therapy
|
1R01CA119045-01A2
|
$329,175
|
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Parental metabolic status and offspring cancer risks
|
1R03CA130131-01
|
$85,000
|
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Synergy between phytochemicals for prostate cancer prevention
|
1R03CA130133-01
|
$85,000
|
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A novel biotherapeutic treatment for prostate cancer
|
1R43CA130228-01
|
$145,306
|
|
CHOI, ANTHONY
|
BEXION PHARMACEUTICALS, INC.
|
|
Cancer Clustering for Residential Histories
|
2R44CA117171-02
|
$374,999
|
|
Jacquez, Geoffrey
|
BIOMEDWARE
|
|
Role of MDM2 in Cell Proliferation and Tumorigenesis
|
2R01CA079804-06A2
|
$277,695
|
|
XIAO, ZHI-XIONG
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Metabolic and Epidemiologic Evaluation of Choline and Betaine Intake
|
1R03CA125763-01A1
|
$87,500
|
|
CHO, EUNYOUNG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genome Wide Association Study: Variants Influencing Steroid Hormone Levels
|
1R03CA128034-01A1
|
$87,500
|
|
Cox, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mitochondrial Haplogroups and Breast Cancer Risk
|
1R03CA130050-01
|
$87,500
|
|
Cox, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Telomere Length and Endometrial Cancer
|
1R03CA132190-01
|
$87,500
|
|
DEVIVO, IMMACULATA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Physicians' Health Study II: Prevention Trial of Vitamins
|
2R01CA097193-06A1
|
$1,550,473
|
|
GAZIANO, J
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Immunological Mediator Genes and Skin Cancer Risk
|
1R03CA132175-01
|
$86,936
|
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cohort Study of Genetic Susceptibility to Breast Cancer
|
2R01CA065725-11A1
|
$405,093
|
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
|
2U01CA098233-05
|
$1,331,791
|
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
3R01CA082036-08S1
|
$66,889
|
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-19
|
$228,408
|
$228,408
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nitric Oxide Synthase Polymorphisms and Risk for Skin Cancer
|
1R03CA130055-01
|
$87,500
|
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Aspartame Intake and the Risk of Cancer
|
1R03CA130054-01
|
$116,101
|
|
SCHERNHAMMER, EVA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Trans-disciplinary Postdoctoral Training in Cancer Biology
|
1T32CA121949-01A2
|
$324,842
|
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Caged micelles for co-delivery of SAHA and geldanamycin in cancer therapy
|
1F32CA130323-01
|
$44,846
|
|
Xiong, May
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Correlates of Cancer Screening for Pacific Islanders in California
|
3U01CA114591-03S2
|
$69,750
|
|
TANJASIRI, SORA
|
CALIFORNIA STATE UNIVERSITY FULLERTON
|
|
Projected Incidence of Cancer Among Pacific Islanders Living in California
|
3U01CA114591-03S3
|
$81,500
|
|
TANJASIRI, SORA
|
CALIFORNIA STATE UNIVERSITY FULLERTON
|
|
Behavior and beliefs related to diet in Native Hawaiians in Southern California
|
3U01CA114591-03S4
|
$71,872
|
|
TANJASIRI, SORA
|
CALIFORNIA STATE UNIVERSITY FULLERTON
|
|
Creating the Pacific Islander Physical Activity Questionnaire (PIPAQ)
|
3U01CA114591-03S5
|
$55,499
|
|
TANJASIRI, SORA
|
CALIFORNIA STATE UNIVERSITY FULLERTON
|
|
Long Circulating Targeted Nanoparticles for non-Hodgkin's Lymphoma Treatment
|
1R43CA130381-01
|
$153,437
|
|
Fong, Peter
|
CARIGENT THERAPEUTICS
|
|
Minority Predoctoral Fellowship Program
|
5F31CA123642-02
|
$2,339
|
|
Montanez-Wiscovich, Marjorie
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Determinants of Chemoprevention by SERMs
|
1R03CA130066-01
|
$77,250
|
|
MONTANO, MONICA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT
|
1R01CA127590-01A1
|
$293,550
|
|
Wang, Zhenghe
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Microfluidic Cell Culture Array for Predictive Toxicity Screening
|
2R44CA117178-02
|
$800,039
|
|
HUNG, PAUL
|
CELLASIC CORPORATION
|
|
S1P Lyase in colon cancer
|
1R01CA129438-01A1
|
$319,440
|
|
SABA, JULIE
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
Total relevant funding to Kaposi Sarcoma for this search: $29,866,256
|